First participant has completed the NEXAF Trial

Another important milestone for NEXAF was reached recently, as the first participant in the NEXAF Trial completed the follow-up examination 12 Months after inclusion. During 12 Months of inclusion and testing in both Trondheim, Bærum and Tromsø, more than 110 participants have been enrolled. The study aims to include 360 participants and will hopefully provide important answers to how exercise could impact on the burden of atrial fibrillation and quality of life in patients suffering from atrial fibrillation.